KMPHARMACEUTICAL Co.,Ltd. (KOSDAQ:225430)
South Korea · Delayed Price · Currency is KRW 558.00
+15.00 (2.76%)
At close: Dec 5, 2025
KMPHARMACEUTICAL Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -4,678 | -4,573 | -1,320 | -3,925 | -611.19 | 470.88 | Upgrade |
Depreciation & Amortization | 1,097 | 1,335 | 1,369 | 1,459 | 1,442 | 1,142 | Upgrade |
Loss (Gain) From Sale of Assets | - | 0.21 | -10.42 | - | -6.56 | 4.66 | Upgrade |
Asset Writedown & Restructuring Costs | - | - | 9.19 | 808.27 | 501.8 | - | Upgrade |
Loss (Gain) From Sale of Investments | -15.7 | -13.98 | -9.92 | -13.93 | -0.61 | 9.16 | Upgrade |
Loss (Gain) on Equity Investments | 460.5 | 403.23 | -64.87 | 75.56 | 674.08 | -25.14 | Upgrade |
Provision & Write-off of Bad Debts | 248.02 | 248.02 | 231.59 | 301.77 | 66.11 | -165.65 | Upgrade |
Other Operating Activities | 892.39 | 1,293 | -232.24 | 1,491 | 331.07 | -72.86 | Upgrade |
Change in Accounts Receivable | -181.27 | -41.36 | 437.05 | 1,008 | -1,026 | -477.09 | Upgrade |
Change in Inventory | -39.06 | -374.79 | 1.94 | 246.46 | 123.75 | -0.53 | Upgrade |
Change in Accounts Payable | 416.95 | 193.93 | 166.16 | -632.95 | 383.86 | -94.39 | Upgrade |
Change in Other Net Operating Assets | 163.97 | -505.8 | 868.64 | -912.03 | 388.6 | 118.08 | Upgrade |
Operating Cash Flow | -1,635 | -2,036 | 1,446 | -93.32 | 2,267 | 909.18 | Upgrade |
Operating Cash Flow Growth | - | - | - | - | 149.37% | - | Upgrade |
Capital Expenditures | -418.88 | -365.1 | -112.77 | -57.69 | -2,365 | -3,737 | Upgrade |
Sale of Property, Plant & Equipment | - | 0.11 | 10.63 | - | 33.58 | 135 | Upgrade |
Sale (Purchase) of Intangibles | -3.76 | -3.76 | -0.59 | - | - | - | Upgrade |
Investment in Securities | 599.87 | -40.03 | -17.52 | 366.36 | -745.84 | 520.12 | Upgrade |
Other Investing Activities | -12.4 | 23.14 | 1 | - | 19 | 151.98 | Upgrade |
Investing Cash Flow | 164.84 | -385.63 | -119.25 | -5,091 | -8,058 | -2,930 | Upgrade |
Short-Term Debt Issued | - | 2,500 | 5,500 | 2,200 | 5,000 | 2,400 | Upgrade |
Long-Term Debt Issued | - | 4,000 | 1,000 | 4,000 | 2,500 | - | Upgrade |
Total Debt Issued | 5,200 | 6,500 | 6,500 | 6,200 | 7,500 | 2,400 | Upgrade |
Short-Term Debt Repaid | - | -4,500 | -2,000 | -700 | -5,000 | -1,900 | Upgrade |
Long-Term Debt Repaid | - | -311.08 | -5,321 | -1,913 | -315.1 | -9,948 | Upgrade |
Total Debt Repaid | -3,504 | -4,811 | -7,321 | -2,613 | -5,315 | -11,848 | Upgrade |
Net Debt Issued (Repaid) | 1,696 | 1,689 | -821.19 | 3,587 | 2,185 | -9,448 | Upgrade |
Issuance of Common Stock | - | - | - | - | - | 16,311 | Upgrade |
Other Financing Activities | -100 | -0 | - | -86 | 10 | 185 | Upgrade |
Financing Cash Flow | 1,596 | 1,689 | -821.19 | 3,501 | 2,195 | 7,048 | Upgrade |
Foreign Exchange Rate Adjustments | 0.56 | 0.05 | -0.13 | - | 0.7 | - | Upgrade |
Net Cash Flow | 126.49 | -732.32 | 505.62 | -1,684 | -3,596 | 5,027 | Upgrade |
Free Cash Flow | -2,054 | -2,401 | 1,333 | -151.02 | -97.92 | -2,828 | Upgrade |
Free Cash Flow Margin | -13.61% | -16.59% | 7.50% | -0.97% | -0.43% | -12.33% | Upgrade |
Free Cash Flow Per Share | -73.78 | -86.09 | 47.48 | -5.42 | -3.52 | -132.12 | Upgrade |
Cash Interest Paid | 593.08 | 578.23 | 630.38 | 349.01 | 170.85 | 514.85 | Upgrade |
Cash Income Tax Paid | 0.14 | -0.23 | -5.38 | 32.74 | -2.22 | -7.59 | Upgrade |
Levered Free Cash Flow | -953.36 | -1,142 | 1,862 | -1,143 | -141.3 | -2,943 | Upgrade |
Unlevered Free Cash Flow | -582.44 | -778.38 | 2,246 | -902.32 | -32.87 | -2,633 | Upgrade |
Change in Working Capital | 360.59 | -728.02 | 1,474 | -290.14 | -129.63 | -453.93 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.